Gábor Cserni

TL;DR: The need for further axillary treatment in patients with breast cancer with low‐volume sentinel node (SN) involvement (micrometastases or smaller) is controversial.

TL;DR: An evaluation of the accuracy of SN biopsy as a staging procedure, the yields of different sectioning methods and the immunohistochemical detection of metastatic cells are reviewed and it is suggested that approximately 18% of the cases may be associated with further nodal (non-SN) metastases.

TL;DR: To define a set of quality indicators that should be routinely measured and evaluated to confirm that the clinical outcome reaches the requested standards, Eusoma has organised a workshop during which twenty four experts from different disciplines have reviewed the international literature and selected the main process and outcome indicators available for quality assurance of breast cancer care.

TL;DR: The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors, and the need to identify women who are at risk.

TL;DR: Evaluated aspects of the current practice of sentinel lymph node (SLN) pathology in breast cancer via a questionnaire based survey to recognise major issues that the European guidelines for mammography screening should address in the next revision.